|
|
|
201-500 employees
View all
|
|
biotechnology
|
|
Sydmarken 11,Søborg (Copenhagen),DK
|
|
Zealand Pharma (Nasdaq: ZEAL) is a biotechnology company focused on the discovery, development, and commercialization of next generation peptide-based medicines that change the lives of people living with metabolic and gastrointestinal diseases. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market. Zealand’s robust pipeline of investigational medicines includes three candidates in late stage development, and one candidate being reviewed for regulatory approval in the United States. Zealand markets V-Go®, an all-in-one basal-bolus insulin delivery option for people with diabetes. License collaborations with Boehringer Ingelheim and Alexion Pharmaceuticals create opportunity for more patients to potentially benefit from Zealand-invented peptide therapeutics.Zealand was founded in 1998 in Copenhagen, Denmark, and has presence throughout the U.S. that includes key locations in New York, Boston, and Marlborough (MA).
|
Zealand Pharma Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75%
|
The widely used Zealand Pharma email format is {f}{last} (e.g. [email protected]) with 75% adoption across the company.
To contact Zealand Pharma customer service number call here +45 8877 3600. To contact Zealand Pharma customer service number in your country click here to find.
Adam Steensberg is the CEO of Zealand Pharma. To contact Adam Steensberg email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.